查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2006200

獸醫眼科護理市場：2026-2032年全球市場預測（按動物類型、產品類型、分銷管道和最終用戶分類）

Veterinary Eye Care Market by Animal Type, Product Type, Distribution Channel, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，獸醫眼科護理市場價值將達到 50.1 億美元，到 2026 年將成長至 53.7 億美元，到 2032 年將達到 83.4 億美元，複合年成長率為 7.53%。

主要市場統計數據
基準年 2025 50.1億美元
預計年份：2026年 53.7億美元
預測年份 2032 83.4億美元
複合年成長率 (%) 7.53%

展望獸醫眼科護理的未來，涵蓋臨床進步、技術進步和商業性變革，這些進步正在重塑獸醫和患者的治療結果。

由於臨床、技術和商業性因素的相互作用，獸醫眼科領域正處於轉折點。影像學和就地檢驗的進步提高了伴侶動物和生產動物眼科評估的標準，而治療方法的創新則改進了感染控制、發炎管理和慢性眼部潤滑的方法。同時，不斷變化的商業環境和飼主的期望也推動了診所和醫院對更高品質眼科護理的需求，迫使醫療機構重新評估其服務內容和資金配置。

對推動獸醫眼科護理的變革性變化進行了清晰的總結，包括在整個生態系統中診斷的去中心化、標靶化的治療以及管道的現代化。

獸醫眼科護理領域正經歷著一場變革性的轉變，這場變革超越了單純的產品改進，涵蓋了全新的護理模式和跨學科合作。攜帶式影像設備和簡化的解讀工具等診斷技術的進步，使得診療重點從集中式的專科機構轉移到了基層醫療機構，從而實現了早期發現和微創干預。這種轉變促使臨床角色重新定義，全科醫師擴大參與到以往由專科醫師診治的疾病中，改變了轉診模式和服務的經濟模式。

分析概述了近期累積關稅措施如何重塑獸醫眼科供應鏈的供應韌性、採購行為和成本動態。

對眼科器械和藥品活性成分進口產品徵收關稅，對獸醫眼科領域的供應鏈、價格趨勢和籌資策略產生了累積影響。關稅帶來的成本壓力促使許多製造商和經銷商重新評估其籌資策略，並強調供應商多元化和改善庫存管理，以減少對特定貿易路線的依賴。因此，某些診斷設備和特殊治療藥物的前置作業時間和成本波動性增加，進而影響了診所和醫院的採購行為。

透過複雜的細分分析，將動物物種、產品類型、銷售管道偏好和最終用戶需求連結起來，揭示差異化的進入路徑和商業性重點。

深入的市場區隔揭示了不同動物種類、產品類型、通路和終端用戶環境下的需求模式、產品偏好和分銷方式的差異。貓狗的需求主要集中在獸醫診斷設備和眼科治療藥物上，這反映了飼主願意投資先進的醫療照護。而牛的需求則更為獨特，它們需要強大、便於現場使用的診斷設備，以及根據其生產和性能特點量身定做的、經濟高效的治療方法。產品類型細分也突顯了診斷設備的普及取決於便攜性和影像解析度之間的平衡，外科手術設備的投資反映了獸醫病例的組成和手術量，以及治療藥物（分為抗感染藥、抗發炎藥和眼科潤滑劑）的選擇取決於物種特異性的藥理特性和給藥的便捷性。

影響美洲、歐洲、中東和非洲以及亞太地區市場採用速度、監管複雜性和分銷管道有效性的關鍵區域趨勢。

區域趨勢決定了創新技術首先在何處得到應用，管理體制如何影響產品註冊，以及哪些分銷模式最為有效。在美洲，伴侶動物醫學領域的臨床應用十分活躍，這得益於成熟的獸醫院網路以及對先進診斷技術和專科療法的重視。供應鏈的柔軟性和與經銷商的成熟關係也促進了產品的快速推廣。相較之下，歐洲、中東和非洲（EMEA）的情況則較為複雜，由於監管差異和分銷管道分散，區域合作夥伴面臨挑戰和機會。在該地區取得成功取決於尊重當地監管專業知識和國家獸醫實踐的在地化商業策略。

這種企業級策略洞察揭示了產品創新、臨床支援和供應鏈韌性如何推動獸醫眼科護理領域的競爭優勢和夥伴關係主導的成長。

在獸醫眼科領域，產品卓越性、服務能力和合作夥伴關係關係之間的交會點正日益成為競爭格局的關鍵。主要企業透過投資提高診斷準確性、以用戶為中心的設備人體工學設計以及針對不同物種劑量和耐受性差異的配方，脫穎而出。除了產品特性之外，那些能夠提供完善的臨床教育、快速技術支援和整合數位化資源的企業也越來越受到獸醫的青睞，因為他們既追求治療效果，也注重易用性。醫療設備製造商、藥品研發商和分銷網路之間的策略夥伴關係正在成為建立整合式醫療路徑的關鍵機制，這些路徑能夠加速產品應用，簡化採購和臨床工作流程。

為相關人員提供切實可行的策略建議，以加強臨床參與、實現供應鏈多元化和協調商業化，從而實現永續推廣和競爭優勢。

致力於在獸醫眼科領域創造價值的產業領導者應採取多管齊下的策略，平衡產品創新、切實可行的商業化和業務永續營運。首先，他們應深化與臨床實踐的合作，透過創建轉化證據和投資於能夠顯著提升診斷準確性、手術效果和治療依從性的實用培訓計畫來實現這一目標。其次，他們應透過採購和物流多元化來降低對特定貿易路線的依賴，並考慮本地化生產和合約生產，從而提高響應速度並減少跨境摩擦。第三，他們應最佳化應對力，根據診所、醫院和研究機構的具體需求客製化產品組合和定價，確保產品既符合臨床工作流程又符合採購週期。

對混合方法研究途徑進行透明的解釋，該方法整合了從業者訪談、技術審查和跨領域分析，以提供可操作的見解。

本研究結合了對臨床醫生、採購經理和技術供應商的初步訪談，以及對同行評審文獻、監管指南和公開可用的診斷和治療產品技術性能數據的系統性回顧。主要調查方法包括對代表性的診所和醫院進行結構化訪談，以了解臨床醫生的工作流程、採購限制和推廣障礙，並透過與分銷合作夥伴的討論評估物流和通路經濟效益。輔助研究著重於技術檢驗研究、製劑概況和監管申報，以確保產品層面的見解是基於已確立的臨床和技術證據。

一項權威的綜合分析強調了在獸醫眼科護理中，將創新、臨床檢驗和營運韌性相結合以改善結果所面臨的策略挑戰。

獸醫眼科護理正朝著更一體化、主導的領域發展，診斷、治療和護理模式相互融合，旨在改善所有物種的治療效果。對臨床需求、技術進步和不斷變化的貿易趨勢的全面分析表明，投資於臨床檢驗、經銷夥伴和供應鏈韌性的機構將獲得長期成功。同時，考慮到區域特徵和特定領域的具體要求，一刀切的方法無法達到理想的效果。尊重物種差異、臨床環境和當地監管實際情況的針對性策略將帶來更好的實施效果和臨床影響。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：獸醫眼科護理市場：依動物類型分類

  • 貓
  • 牛
  • 狗
  • 馬

第9章：獸醫眼科護理市場：依產品類型分類

  • 診斷設備
  • 手術器械
  • 治療藥物
    • 抗感染藥物
    • 抗發炎藥
    • 眼藥水潤滑劑

第10章：獸醫眼科護理市場：依通路分類

  • 線上管道
  • 離線

第11章 獸醫眼科護理市場：依最終使用者分類

  • 研究機構
  • 獸醫診所
  • 動物醫院

第12章 獸醫眼科護理市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 獸醫眼科護理市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 獸醫眼科護理市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國：獸醫眼科護理市場

第16章 中國：獸醫眼科護理市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Accutome, Inc.
  • An-Vision GmbH
  • Bausch+Lomb Incorporated
  • Baxter International, Inc.
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale SA
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • HEINE Optotechnik GmbH & Co. KG
  • Iridex Corporation
  • I-MED Animal Health
  • Jorgensen Laboratories, LLC
  • LKC Technologies, Inc.
  • Merck & Co., Inc.
  • Occuity Ltd
  • Optomed Plc
  • Reichert, Inc.
  • Revenio Group Oyj
  • Sandoz
  • Zoetis Inc.
Product Code: MRR-B168537792D0

The Veterinary Eye Care Market was valued at USD 5.01 billion in 2025 and is projected to grow to USD 5.37 billion in 2026, with a CAGR of 7.53%, reaching USD 8.34 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 5.01 billion
Estimated Year [2026] USD 5.37 billion
Forecast Year [2032] USD 8.34 billion
CAGR (%) 7.53%

A forward-looking introduction to veterinary ophthalmic care that frames clinical evolution, technology adoption, and commercial shifts reshaping practitioner and patient outcomes

The veterinary eye care sector stands at an inflection point driven by converging clinical, technological, and commercial forces. Advances in diagnostic imaging and point-of-care testing have elevated the standard of ocular assessment across companion and production animals, while therapeutic innovation has refined approaches to infection control, inflammation management, and chronic ocular lubrication. At the same time, shifting practice economics and owner expectations are accelerating demand for higher-quality eye care within clinics and hospitals, prompting providers to reassess service mixes and capital allocation.

Practitioners now balance acute surgical interventions with long-term management strategies, and they increasingly rely on integrated diagnostics to inform treatment pathways. Concurrently, manufacturers are adapting product portfolios to align with evolving clinician workflows and regulatory environments. As a result, the ecosystem is moving toward closer collaboration between product developers, distributors, and end users to shorten time-to-adoption and to support evidence-based therapeutic protocols. Looking ahead, sustained improvements in clinical training, coupled with broader access to portable diagnostics, will continue to shape how ocular conditions are detected, triaged, and treated across species and care settings.

A clear summary of the transformative shifts driving veterinary ocular care including diagnostics decentralization, therapeutic targeting, and channel modernization across the ecosystem

The landscape of veterinary eye care has undergone transformative shifts that extend beyond incremental product improvements to encompass new care models and cross-disciplinary collaboration. Diagnostic sophistication has migrated from centralized specialty centers to primary care settings through portable imaging and simplified interpretation tools, enabling earlier detection and less invasive interventions. This transition has fostered a redefinition of clinical roles, with general practitioners increasingly managing conditions once reserved for specialists, thereby altering referral dynamics and service economics.

At the same time, therapeutics are becoming more targeted, driven by advances in formulation science and a clearer understanding of ocular pharmacokinetics across species. These developments are complemented by digital tools that support remote monitoring and tele-ophthalmology consultations, which broaden access while imposing new requirements for data interoperability and clinician training. In parallel, supply chain modernization and omnichannel distribution strategies have reshaped product availability, compelling manufacturers to invest in direct engagement with veterinary networks. Together, these shifts are creating an environment where agility, clinical evidence, and channel alignment determine who captures clinical mindshare and long-term trust among practitioners and animal owners.

An analytical overview of how recent and cumulative tariff measures have reshaped supply resilience, procurement behavior, and cost dynamics within veterinary ophthalmic supply chains

The introduction of tariffs affecting imports linked to ocular devices and active pharmaceutical ingredients has had a cumulative impact on supply chains, pricing dynamics, and procurement strategies within veterinary eye care. Tariff-induced cost pressures have prompted many manufacturers and distributors to reassess sourcing strategies, favoring supplier diversification and enhanced inventory management to mitigate exposure to concentrated trade routes. As a consequence, product lead times and cost-to-clinic for certain diagnostic equipment and specialty therapeutics have shown increased variability, which in turn has influenced purchasing behaviors among clinics and hospitals.

Furthermore, regulatory compliance and customs administration requirements have placed additional operational burdens on smaller suppliers and distributors, encouraging consolidation among logistics partners and fostering partnerships with regional manufacturers that can provide more predictable supply. Clinicians and procurement teams have adapted by prioritizing product portfolios that demonstrate both clinical efficacy and resilient supply pathways. In addition, the tariffs environment has accelerated interest in domestic manufacturing and contract manufacturing options that reduce tariff exposure, while also increasing the emphasis on product standardization to simplify cross-border regulatory approvals. Taken together, these effects have reshaped strategic sourcing, inventory policy, and investment decisions across the veterinary eye care value chain.

A nuanced segmentation analysis that connects animal type, product category, channel preferences, and end-user requirements to reveal differentiated adoption pathways and commercial priorities

Insightful segmentation reveals how demand patterns, product preferences, and distribution practices vary across animal types, product categories, channels, and end-user settings. Cats and dogs dominate demand for clinic-based diagnostics and ophthalmic therapeutics, reflecting high owner willingness to invest in advanced care, whereas cattle and horses drive a distinct set of needs focused on robust, field-ready diagnostics and cost-effective therapeutic regimens suitable for production and performance contexts. In turn, product type segmentation highlights how diagnostics equipment adoption is shaped by the balance between portability and image resolution, how surgical equipment investments reflect clinic case mix and surgical throughput, and how therapeutics-divided into anti infectives, anti inflammatories, and ocular lubricants-are selected based on species-specific pharmacology and administration practicality.

Distribution channel dynamics further influence access and adoption, with direct sales channels enabling close vendor-clinic relationships and technical support, online channels expanding reach for routine consumables, retail pharmacies offering convenience to pet owners, and veterinary distributors providing bundled solutions and inventory services for larger networks. Finally, end-user segmentation across research institutes, veterinary clinics, and veterinary hospitals underscores divergent purchasing rationales: research entities prioritize technical capabilities and reproducibility, clinics focus on cost-effectiveness and workflow integration, and hospitals emphasize comprehensive capability, including advanced surgical suites and in-house diagnostics. Synthesizing these dimensions reveals where manufacturers and channel partners should tailor messaging, training, and product design to align with the operational realities of each segment.

Key regional dynamics that determine adoption velocity, regulatory complexity, and channel effectiveness across the Americas, Europe Middle East & Africa, and Asia-Pacific landscapes

Regional dynamics shape where innovation is adopted first, how regulatory regimes influence product registration, and which distribution models prove most effective. The Americas exhibit strong clinical adoption in companion animal care, supported by established veterinary clinic networks and an emphasis on advanced diagnostics and specialty therapeutics, while supply chain flexibility and mature distributor relationships facilitate rapid product rollouts. In contrast, Europe, Middle East & Africa present a heterogeneous landscape where regulatory variability and fragmented distribution create both challenges and opportunities for regional partners; success in this region hinges on localized regulatory expertise and tailored commercial strategies that respect national practice patterns.

Asia-Pacific stands out for rapid clinics expansion, growing pet ownership, and increasing investment in veterinary education, all of which create fertile ground for portable diagnostics and scalable therapeutic solutions. However, the region also demands localized value propositions, competitive pricing structures, and partnerships with national distributors to navigate diverse regulatory frameworks. Across all regions, strategic entry and scale-up require close attention to local training needs, reimbursement or payment behaviors, and the presence of regional manufacturing or contract production capabilities that can mitigate trade-related volatility. By aligning product positioning and go-to-market models with these regional nuances, manufacturers can optimize uptake and establish durable commercial footprints.

Strategic company-level insights that expose how product innovation, clinical support, and supply resilience drive competitive advantage and partnership-led growth in ophthalmic veterinary care

Competitive dynamics in veterinary eye care are increasingly defined by an intersection of product excellence, service capability, and collaborative partnerships. Leading firms differentiate through investments in diagnostic accuracy, user-centered device ergonomics, and formulations that account for interspecies variation in dosing and tolerability. Beyond product attributes, companies that provide robust clinical education, responsive technical support, and integrated digital resources gain preference among veterinary clinicians who seek both outcomes and ease of use. Strategic partnerships between device manufacturers, pharmaceutical developers, and distribution networks are emerging as critical mechanisms to accelerate adoption and to create bundled care pathways that simplify procurement and clinical workflow.

Mergers, acquisitions, and alliance-building are also shaping capability sets, enabling faster access to complementary technologies and new channels. At the same time, smaller innovators contribute by addressing niche needs-such as field-friendly diagnostics and species-specific therapeutic formulations-that larger players may overlook. Importantly, supply chain resilience and regulatory intelligence have become differentiators; companies that can reliably deliver products with clear compliance documentation and predictable logistics enjoy stronger trust among large hospital networks and procurement partners. For market participants, the combination of clinical validation, localized support, and supply reliability determines which companies secure long-term clinical partnerships.

Actionable strategic recommendations for stakeholders to strengthen clinical engagement, diversify supply chains, and align commercialization for sustained adoption and competitive resilience

Industry leaders seeking to capture value in veterinary eye care should adopt a multi-dimensional strategy that balances product innovation with pragmatic commercialization and operational resilience. First, deepen clinical engagement by investing in translational evidence generation and hands-on training programs that demonstrate clear benefits in diagnostic accuracy, surgical outcomes, and therapeutic adherence. Second, diversify sourcing and logistics to reduce exposure to concentrated trade routes, and consider regional manufacturing or contract production to improve responsiveness and lower cross-border friction. Third, tailor go-to-market approaches by aligning product bundles and pricing with the specific needs of clinics, hospitals, and research institutes, ensuring that offerings match both clinical workflows and procurement cycles.

Additionally, embrace digital tools to support tele-ophthalmology, remote monitoring, and clinician decision support, thereby extending the utility of diagnostic investments and strengthening customer lock-in. Cultivate partnerships across the value chain-linking manufacturers, distributors, and training providers-to deliver bundled solutions that simplify purchasing and shorten learning curves. Finally, prioritize regulatory readiness and post-market surveillance to minimize approval delays and to build credibility with clinicians and buyers. By integrating these elements, industry leaders can create defensible positions that balance short-term commercial wins with sustainable clinical impact.

A transparent explanation of the mixed-methods research approach that integrates practitioner interviews, technical review, and cross-segmentation analysis to deliver actionable intelligence

This research synthesizes primary engagement with clinical practitioners, procurement leaders, and technology providers together with a structured review of peer-reviewed literature, regulatory guidance, and publicly available technical performance data for diagnostic and therapeutic products. Primary inputs included structured interviews conducted across a representative set of clinics and hospitals to capture practitioner workflows, procurement constraints, and adoption barriers, complemented by discussions with distribution partners to assess logistics and channel economics. Secondary research focused on technical validation studies, formulation profiles, and regulatory submissions to ensure product-level insights were grounded in established clinical and technical evidence.

Analytical methods incorporated cross-segmentation triangulation to reconcile perspectives across animal type, product category, distribution channel, and end-user setting, enabling robust insight into where clinical need and commercial opportunity intersect. Scenario analysis was used to evaluate the operational implications of supply chain disruptions and tariff shifts, while qualitative synthesis identified recurring themes that inform strategic recommendations. Throughout the methodology, emphasis was placed on data integrity, respondent confidentiality, and reproducibility of findings, ensuring the report provides decision-useful intelligence for commercial leaders and clinical stakeholders.

A conclusive synthesis highlighting strategic imperatives for aligning innovation, clinical validation, and operational resilience to advance veterinary ocular care outcomes

Veterinary eye care is evolving into a more integrated, evidence-driven discipline where diagnostics, therapeutics, and care delivery models converge to improve outcomes across species. The synthesis of clinical demand, technological progress, and shifting trade dynamics demonstrates that long-term success will favor organizations that invest in clinical validation, channel partnerships, and supply chain resilience. At the same time, regional nuances and segment-specific requirements mean that one-size-fits-all approaches will underperform; targeted strategies that respect species differences, care settings, and local regulatory realities will deliver superior adoption and clinical impact.

In closing, the sector presents tangible opportunities for companies that can harmonize product innovation with pragmatic commercialization and operational robustness. Decision-makers should prioritize initiatives that establish clinical credibility, ensure reliable product availability, and provide measurable benefits to practitioners and owners alike. With deliberate investment in these areas, stakeholders can both elevate standards of ocular care and capture enduring commercial advantage within an increasingly sophisticated veterinary healthcare ecosystem.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Veterinary Eye Care Market, by Animal Type

  • 8.1. Cats
  • 8.2. Cattle
  • 8.3. Dogs
  • 8.4. Horses

9. Veterinary Eye Care Market, by Product Type

  • 9.1. Diagnostics Equipment
  • 9.2. Surgical Equipment
  • 9.3. Therapeutics
    • 9.3.1. Anti Infectives
    • 9.3.2. Anti Inflammatories
    • 9.3.3. Ocular Lubricants

10. Veterinary Eye Care Market, by Distribution Channel

  • 10.1. Online Channels
  • 10.2. Offline

11. Veterinary Eye Care Market, by End User

  • 11.1. Research Institutes
  • 11.2. Veterinary Clinics
  • 11.3. Veterinary Hospitals

12. Veterinary Eye Care Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Veterinary Eye Care Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Veterinary Eye Care Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Veterinary Eye Care Market

16. China Veterinary Eye Care Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Accutome, Inc.
  • 17.6. An-Vision GmbH
  • 17.7. Bausch + Lomb Incorporated
  • 17.8. Baxter International, Inc.
  • 17.9. Boehringer Ingelheim International GmbH
  • 17.10. Ceva Sante Animale S.A.
  • 17.11. Dechra Pharmaceuticals PLC
  • 17.12. Elanco Animal Health Incorporated
  • 17.13. HEINE Optotechnik GmbH & Co. KG
  • 17.14. Iridex Corporation
  • 17.15. I-MED Animal Health
  • 17.16. Jorgensen Laboratories, LLC
  • 17.17. LKC Technologies, Inc.
  • 17.18. Merck & Co., Inc.
  • 17.19. Occuity Ltd
  • 17.20. Optomed Plc
  • 17.21. Reichert, Inc.
  • 17.22. Revenio Group Oyj
  • 17.23. Sandoz
  • 17.24. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VETERINARY EYE CARE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VETERINARY EYE CARE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL VETERINARY EYE CARE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES VETERINARY EYE CARE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA VETERINARY EYE CARE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL VETERINARY EYE CARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY CATS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY CATS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY CATS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY CATTLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY CATTLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY DOGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY DOGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY DOGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY HORSES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY HORSES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY HORSES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY DIAGNOSTICS EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY DIAGNOSTICS EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY DIAGNOSTICS EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY SURGICAL EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY SURGICAL EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY SURGICAL EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY THERAPEUTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY THERAPEUTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY ANTI INFECTIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY ANTI INFECTIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY ANTI INFECTIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY ANTI INFLAMMATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY ANTI INFLAMMATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY ANTI INFLAMMATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY OCULAR LUBRICANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY OCULAR LUBRICANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY OCULAR LUBRICANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS VETERINARY EYE CARE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS VETERINARY EYE CARE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS VETERINARY EYE CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS VETERINARY EYE CARE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 57. AMERICAS VETERINARY EYE CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS VETERINARY EYE CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 59. NORTH AMERICA VETERINARY EYE CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA VETERINARY EYE CARE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA VETERINARY EYE CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 62. NORTH AMERICA VETERINARY EYE CARE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA VETERINARY EYE CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA VETERINARY EYE CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA VETERINARY EYE CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA VETERINARY EYE CARE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. LATIN AMERICA VETERINARY EYE CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA VETERINARY EYE CARE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 69. LATIN AMERICA VETERINARY EYE CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 70. LATIN AMERICA VETERINARY EYE CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE, MIDDLE EAST & AFRICA VETERINARY EYE CARE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE, MIDDLE EAST & AFRICA VETERINARY EYE CARE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA VETERINARY EYE CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA VETERINARY EYE CARE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA VETERINARY EYE CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA VETERINARY EYE CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE VETERINARY EYE CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE VETERINARY EYE CARE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE VETERINARY EYE CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE VETERINARY EYE CARE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE VETERINARY EYE CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE VETERINARY EYE CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. MIDDLE EAST VETERINARY EYE CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. MIDDLE EAST VETERINARY EYE CARE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. MIDDLE EAST VETERINARY EYE CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. MIDDLE EAST VETERINARY EYE CARE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST VETERINARY EYE CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 88. MIDDLE EAST VETERINARY EYE CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. AFRICA VETERINARY EYE CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. AFRICA VETERINARY EYE CARE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. AFRICA VETERINARY EYE CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. AFRICA VETERINARY EYE CARE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 93. AFRICA VETERINARY EYE CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 94. AFRICA VETERINARY EYE CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC VETERINARY EYE CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC VETERINARY EYE CARE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC VETERINARY EYE CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC VETERINARY EYE CARE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC VETERINARY EYE CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC VETERINARY EYE CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. ASEAN VETERINARY EYE CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. ASEAN VETERINARY EYE CARE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. ASEAN VETERINARY EYE CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. ASEAN VETERINARY EYE CARE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 106. ASEAN VETERINARY EYE CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 107. ASEAN VETERINARY EYE CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. GCC VETERINARY EYE CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GCC VETERINARY EYE CARE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. GCC VETERINARY EYE CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. GCC VETERINARY EYE CARE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 112. GCC VETERINARY EYE CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 113. GCC VETERINARY EYE CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPEAN UNION VETERINARY EYE CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPEAN UNION VETERINARY EYE CARE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPEAN UNION VETERINARY EYE CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPEAN UNION VETERINARY EYE CARE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPEAN UNION VETERINARY EYE CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPEAN UNION VETERINARY EYE CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. BRICS VETERINARY EYE CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. BRICS VETERINARY EYE CARE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. BRICS VETERINARY EYE CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. BRICS VETERINARY EYE CARE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 124. BRICS VETERINARY EYE CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 125. BRICS VETERINARY EYE CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. G7 VETERINARY EYE CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. G7 VETERINARY EYE CARE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. G7 VETERINARY EYE CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. G7 VETERINARY EYE CARE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 130. G7 VETERINARY EYE CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. G7 VETERINARY EYE CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. NATO VETERINARY EYE CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. NATO VETERINARY EYE CARE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. NATO VETERINARY EYE CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. NATO VETERINARY EYE CARE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 136. NATO VETERINARY EYE CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. NATO VETERINARY EYE CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL VETERINARY EYE CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. UNITED STATES VETERINARY EYE CARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 140. UNITED STATES VETERINARY EYE CARE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. UNITED STATES VETERINARY EYE CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. UNITED STATES VETERINARY EYE CARE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 143. UNITED STATES VETERINARY EYE CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 144. UNITED STATES VETERINARY EYE CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. CHINA VETERINARY EYE CARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 146. CHINA VETERINARY EYE CARE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. CHINA VETERINARY EYE CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. CHINA VETERINARY EYE CARE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 149. CHINA VETERINARY EYE CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 150. CHINA VETERINARY EYE CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)